CLINICAL_TRIALS
trial_result
· 2011-09-26
Clinical Trial Update: A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Dry Eye Disease [Phase 4]
Summary
A four-week Phase 4 trial comparing azithromycin ophthalmic solution 1% versus placebo in Dry Eye Disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Dry Eye Disease | Phase 4 | Status: COMPLETED